4.10
0.24%
+0.010
Adc Therapeutics SA (ADCT) 最新ニュース
A look into Adc Therapeutics SA (ADCT)'s deeper side – Sete News - SETE News
SETE News
ADC Therapeutics SA's $105 Million Common Shares Offering – Global Legal Chronicle - Global Legal Chronicle
Global Legal Chronicle
ADC Therapeutics wird an der H.C. Wainwright 2nd Annual BioConnect Investor Conference an der NASDAQ teilnehmen
GlobeNewswire Inc.
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Singapore News
Yahoo Singapore News
The Adc Therapeutics SA (ADCT) had a good session last reading, didn't it? – US Post News - US Post News
US Post News
Financial Metrics Exploration: Understanding Adc Therapeutics SA (ADCT) Through Ratios – DWinneX - The Dwinnex
The Dwinnex
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ - GlobeNewswire
GlobeNewswire
ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
GlobeNewswire Inc.
ADC Therapeutics Unveils Strategic Insights in New Presentation - TipRanks.com - TipRanks
TipRanks
ADC Therapeutics down 7% following new corporate presentation - Seeking Alpha
Seeking Alpha
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo News UK
Yahoo News UK
ADC Therapeutics SA (ADCT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Movies UK
Yahoo Movies UK
ADC Therapeutics SA (ADCT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Movies UK
Yahoo Movies UK
Financial Comparison: ADC Therapeutics (NYSE:ADCT) vs. Acasti Pharma (NASDAQ:ACST) - Defense World
Defense World
Redmile Group acquires $69.1 million in ADC Therapeutics pre-funded warrants - Investing.com
Investing.com
Public equity report: iTeos, ADC Therapeutics, Eledon draw fundings - BioCentury
BioCentury
Analysts Are Updating Their ADC Therapeutics SA (NYSE:ADCT) Estimates After Its First-Quarter Results - Simply Wall St
Simply Wall St
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference - Informazione.it
Informazione.it
Adc therapeutics CEO sells shares worth over $133k - Investing.com
Investing.com
ADC Therapeutics nimmt an der RBC Capital Markets Global Healthcare Conference 2024 teil
GlobeNewswire Inc.
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire Inc.
ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Yahoo Finance
Yahoo Finance
Insider Selling: ADC Therapeutics SA (NYSE:ADCT) CEO Sells 29,731 Shares of Stock - MarketBeat
MarketBeat
ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations - Simply Wall St
Simply Wall St
ADC Therapeutics (NYSE:ADCT) Price Target Cut to $8.00 by Analysts at HC Wainwright - Defense World
Defense World
ADC Therapeutics veröffentlicht die Finanzergebnisse des ersten Quartals 2024 und gibt aktuelle Informationen zum Geschäftsverlauf bekannt
GlobeNewswire Inc.
GB01-VA-PL2202, a Claudin-6-targeting ADC with potent antitumor efficacy and bystander killing activity - BioWorld Online
BioWorld Online
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
ADC Therapeutics SA (NYSE:ADCT) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
ADC Therapeutics kündigt garantiertes Angebot an Stammaktien und Pre-Funded Warrants im Umfang von USD 105 Mio. an
GlobeNewswire Inc.
ADC Therapeutics gibt erste Daten der von einem Prüfarzt initiierten klinischen Phase-II-Studie mit ZYNLONTA® bei Patienten mit rezidiviertem/refraktärem Marginalzonen-Lymphom bekannt
GlobeNewswire Inc.
ZYNLONTA shows high response rate in lymphoma trial - Investing.com South Africa
Investing.com South Africa
ZYNLONTA shows high response rate in lymphoma trial - Investing.com
Investing.com
ADC Therapeutics announces $105 million shares offering - Investing.com India
Investing.com India
ADC Therapeutics announces $105 million shares offering By Investing.com - Investing.com
Investing.com
ADC Therapeutics stock jumps on earnings beat By Investing.com - Investing.com Nigeria
Investing.com Nigeria
ADC Therapeutics SA 2024 Q1 - Results - Earnings Call Presentation (NYSE:ADCT) - Seeking Alpha
Seeking Alpha
ADC Therapeutics : 1Q 2024 Earnings Call - Marketscreener.com
Marketscreener.com
ADC Therapeutics stock jumps on earnings beat - Investing.com India
Investing.com India
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants - GlobeNewswire
GlobeNewswire
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
GlobeNewswire Inc.
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
ADC Therapeutics Jumps on Earnings Beat By Investing.com - Investing.com Canada
Investing.com Canada
ADC Therapeutics SA Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
Marketscreener.com
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire Inc.
ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients ... - Marketscreener.com
Marketscreener.com
ADC Therapeutics stock jumps on earnings beat - Investing.com India
Investing.com India
After Plunging -34.06% in 4 Weeks, Here's Why the Trend Might Reverse for ADC Therapeutics SA (ADCT) - Yahoo Singapore News
Yahoo Singapore News
ADC Therapeutics (ADCT) Set to Announce Quarterly Earnings on Monday - Defense World
Defense World
ADC Therapeutics (ADCT) Set to Announce Quarterly Earnings on Monday - Defense World
Defense World
大文字化:
|
ボリューム (24 時間):